Annexon rises after Q1 loss narrows

Annexon

13/05/2024 15:03

** Shares of drug developer Annexon  ANNX.O  rise 7.2% to
$5.09
    ** Company posts Q1 loss of 21 cents/shr vs 52 cents/shr a
year ago
    ** ANNX's cash and cash equivalents and short-term
investments at $264.9 mln as of March 31 
    ** Company expects its cash, cash equivalents and marketable
securities to be sufficient to fund its planned operating
expenses into mid-2026
    ** Stock up 10.6% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))